Millennium Management’s Ambrx Biopharma Inc AMAM Stock Holding History

Millennium Management’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-112,300	Closed	-$1.29M	–	6702
2023 Q3	$1.29M	Buy	+112,300	New	+$1.53M	﹤0.01%	3981
2023 Q2	–	Sell	-20,000	Closed	-$178K	–	6902
2023 Q1	$178K	Buy	+20,000	New	+$101K	﹤0.01%	5220

Millennium Management's AMAM Position: Q1 2024 in Review

Millennium Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 432,709 shares — an estimated $6.16M sold.

Millennium Management first reported a position in AMAM in Q2 2021 and held it in 11 quarters. The position peaked at $6.16M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Millennium Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Millennium Management sold 432,709 Ambrx Biopharma Inc shares in Q1 2024, an estimated $6.16M.
Millennium Management first reported a position in Ambrx Biopharma Inc in Q2 2021 and held it in 11 quarters.
Millennium Management's Ambrx Biopharma Inc position peaked at $6.16M in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.